Exchange: NASDAQ·Updated 07:52 PM EDT
ELDN logo

ELDN Eledon Pharmaceuticals Inc

$2.98
$0.22
(6.88%)
Today
Closed $2.98
$0.05
(1.68%)
After Hours
Reported EarningsAug 13
Mkt Cap$260.04M
Vol1.84M

About ELDN

Eledon Pharmaceuticals, Inc. is a clinical stage biotechnology company, which engages in development of therapies to protect transplanted organs and prevent rejection. The firm also focuses on development of therapy to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, a humanized IgG1 anti-CD40L antibody with high affinity for CD40 ligand (CD40L), a biological target with broad therapeutic potential. The company was founded on March 26, 2004 and is headquartered in Irvine, CA.
82

Extremely Bullish Sentiment

How do you feel about ELDN?

Advertisement|Remove ads.